financetom
Business
financetom
/
Business
/
S&P 500 Companies to Close Out Earnings Season With Above-Consensus Profit, Oppenheimer Data Show
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
S&P 500 Companies to Close Out Earnings Season With Above-Consensus Profit, Oppenheimer Data Show
Nov 24, 2025 9:48 AM

12:37 PM EST, 11/24/2025 (MT Newswires) -- S&P 500 companies are set to wrap up this earnings cycle with quarterly profits well above market estimates, Oppenheimer Asset Management said in a note emailed Monday.

The reporting season is largely over, with nearly 95% of the companies in the benchmark equity index having announced latest quarterly results. Earnings are up 13% on sales growth of 8.3%, according to Oppenheimer.

FactSet's bottom-up estimates put analysts' projected earnings growth at 8% ahead of the latest earnings season, the Oppenheimer report showed.

"S&P 500 earnings have persisted in surprising to the upside across most sectors for (third-quarter) earnings season," Oppenheimer Asset Management Chief Investment Strategist John Stoltzfus said.

As of last Friday, 10 of the 11 sectors had growth in earnings, led by technology with a 29% increase year over year, followed by financials. Energy was the only sector that reported an earnings drop.

All sectors posted higher sales annually, driven by technology and health, which delivered 16% and 10% growth, respectively.

Another 11 S&P 500 companies are scheduled to release their quarterly results this week, the brokerage said.

Dell Technologies ( DELL ) and Workday (WDAY) are due to announce their financials on Tuesday. Deere & Co. ( DE ) reports on Wednesday.

The record-long federal government shutdown, which ended earlier this month, has impacted the official data flow at a time when Wall Street is looking for clues around the Federal Reserve's next monetary policy action on Dec. 10.

The Bureau of Labor Statistics won't publish October reports on employment and consumer inflation, while data for November will now be released after the Fed's two-day policy meeting.

"For all the value that alternative data providers and private sources can offer, the missing data from government agencies is causing the markets to wobble and investor sentiment to sour near term," Stoltzfus said. "The slate of information available to ascertain what the Fed's rate decision in December might be lacks the level of clarity that the market is accustomed to having."

The probability that the Federal Open Market Committee will lower rates by 25 basis points next month rose to 77% on Monday from 71% on Friday, according to the CME FedWatch tool.

Price: 127.45, Change: +4.94, Percent Change: +4.03

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved